|
|
|
|
|
|
|
|
|
|
"Chemotherapy resulted in an overall response rate of 42% in this heavily pretreated patient population, including a 55% response rate for carboplatin and/or a taxane," said Ang. "If these results are confirmed in a larger patient population, they could remain an option for these patients, even if they have demonstrated prior resistance."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.